1. Abu AI, Ajikobi DO, Bachelard H, Cupples WA, S a levsky FC: Responses of mesenteric and renal blood flow dynamics to acute denervation in anesthetized rats; Am J Physiol. 1998, 275 (5), S.R1543-R1552

2. Aderka D, Le JM, Vilcek J: IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cu l tured human monocytes, U937 cells, and in mice; J Immunol. 1989, 143 (11), S.3517-3523

3. Ahrenholz DH, Simmons RL: Fibrin in peritonitis. Beneficial and adverse effects of fibrin in experimental E.coli peritonitis; Surgery. 1980, 88 (1), S.41-47

4. Ammons WS, Kung AH: Recombinant amino terminal fragment of bactericidal/permeability- increasing pr o tein prevents hemodynamic responses to endotoxin; Circ Shock. 1993, 41, S.176-184

5. Anderson RN: Leading Causes for 2000. National Vital Statistics Reports; Hrsg.: CDC Atlanta: Band 50. 2002 S.86

6. Angus Dc, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care; Crit Care Med. 2001, 29 (7), S.1303-1310

7. Angus DC, Wax RS: Epidemiology of sepsis: An update; Crit Care Med. 2001, 29 (7 Suppl), S.S109-S116

8. Arfors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM: A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo; Blood. 1987, 69 (1), S.338-340

9. Arndt H, Palitzsch KD, Anderson DC, Rusche J, Grisham MB, Granger DN: Leucocyte-endothelial cell adh e sion in a model of intestinal inflammation; Gut. 1995, 37 (3), S.374-379

10. Arvidsson S, Falt K, Marklund S, Haglund U: Role of free oxygen radicals in the development of gastroi n testinal mucosal damage in Escherichia coli sepsis; Circ Shock. 1985, 18 (4), S.383-393

11. Baatz H, Pleyer U, Thiel HJ, Hammer C: In Vivo Study of Leukocyte-Endothelium Interaction in End o toxin-Induced Uveitis; Invest Ophtalmol Vis Sci. 1995, 36, S.1960-1967

12. Bahrami S, Redl H, Leichtfried G, Yu Y, Schlag G: Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats; Infect Immun. 1994, 62 (1), S.99-105

13. Baker JW, Deitch EA, Li M, Berg RD, Specian RD: Hemorrhagic shock induces bacterial translocation from the gut; J Trauma. 1988, 28 (7), S.896-906

14. Bakker J, Zhang H, Depierreux M, van Asbeck S, Vincent J: Effects of N-acetylcysteine in endotoxic shock; Crit Care . 1994, 9 (4), S.236-243

15. Balk RA: Severe sepsis and septic shock. Definitions, epidemology, and clinical manifestations; Crit Care Clin . 2000, 16 (2), S.179-192

16. Barroso AJ, Schmid SG, Zweifach BW, Mathison JC: Polymorphonuclear neutrophil contribution to induced tolera n ce to bacterial lipopolysaccharide; Am Heart Assoc. 1991, 69 (5), S.1196-1206

17. Bauer M: Pathophysiologie der Sepsis; Anaesthesist . 1996, 45 (4), S.312-322

18. Bazil V, Strominger JL : Shedding as a mechanism of down-modulation of CD14 on stimulated human m o nocytes; J Immunol . 1991, 147 (5), S.1567-1574

19. Berg RD: Bacterial translocation from the gastrointestinal tract; Trends Microbiol. 1995, 3 (4), S.149-154

20. Bernard GR, Lucht WD, Niedermeyer ME, Snapper JR, Ogletree ML, Brigham KL: Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granuloc y te function; J Clin Invest. 1984, 73, S.1772-1784

21. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ: Efficacy and safety of recombinant human activated protein C for severe sepsis; N Engl J Med . 2001, 344 (10), S.699-709

22. Beutler B, Grau GE: Tumor necrosis factor in the pathogenesis of infectious diseases; Crit Care Med . 1993, 21 (10 Suppl), S.S423-S435

23. Beutler B, Poltorak A: Sepsis and evolution of the innate immune response; Crit Care Med . 2001, 29 (7 Suppl), S.S2-S6

24. Bevilacqua MP, Stengelin S, Gimbrone-MA J, Seed B: Endothelial leukocyte adhesion molecule 1: An ind u cible receptor for neutrophils related to complement regulatory prot e ins and lectins; Science. 1989, 243 (4895), S.1160-1165

25. Blackwell TS, Christman JW : Sepsis and cytokines: Current status; Br J Anaesth. 1996, 77 (1), S.110-117

26. Bochud PY, Calandra T: Pathogenesis of sepsis: new concepts and implications for fut u re treatment; Brit Med J . 2003, 326 (7383), S.262-266

27. Böhrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D, Bottiger BW, Stern DM, Waldherr R, Sa e ger HD, Ziegler R, Bierhaus A, Martin E, Nawroth PP: Role of NFkappaB in the mortality of sepsis ; J Clin Invest . 1997, 100 (5), S.972-985

28. Boillot A, Massol J, Maupoil V, Grelier R, Bernard B, Capellier G, Berthelot A, Barale F: Myocardial and vascular adrenergic alterations in a rat model of endotoxin shock: reversal by an anti-tumor necrosis factor-alpha monoclonal antibody ; Crit Care Med. 1997, 25 (3), S.504-511

29. Bone RC: Immunologic dissonance: A continuing evolution in our understanding of the systemic inflamm a tory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS); Ann Intern Med . 1996, 125 (8), S.680-687

30. Bone RC: Let's agree on terminology: Definitions of sepsis; Crit Care Med . 1991, 19 (7) , S.973-976

31. Bone RC: The Pathogenesis of Sepsis; Ann Intern Med . 1991, 115 (6), S.457-469

32. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS; Crit Care Med . 1996, 24 (7), S.1125-1128

33. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation; Crit Care Med. 1996, 24 (1), S.163-172

34. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care M e dicine; Chest. 1992, 101 (6), S.1644-1655

35. Bone RC, Fisher CJ, Jr., Clemmer TP, Slotman GJ, Metz CA, Balk RA: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock; N Engl J Med. 1987, 317 (11), S.653-658

36. Bone RC, Fisher CJ, Jr., Clemmer TP, Slotman GJ, Metz CA, Balk RA: Sepsis syndrome: A valid clinical entity. Methylprednisolone Severe Sepsis Study Group; Crit Care Med. 1989, 17 (5), S.389-393

37. Bone RC, Grodzin CJ, Balk RA : Sepsis: A new hypothesis for pathogenesis of the disease pr o cess; Chest. 1997, 112 (1), S.235-243

38. Bone RC, Sprung CL, Sibbald WJ : Definitions for sepsis and organ failure; Crit Care Med . 1992, 20 (6), S.724-726

39. Bonfanti R, Furie BC, Furie B, Wagner DD: PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells; Blood . 1989., 73 (5) , S.1109-1112

40. Bouvier C, Guc MO, Furman BL, Parratt JR: Platelet activating factor impairs pressor responses to noradr e naline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity; Circ Shock . 1994, 42 (1), S.14-19

41. Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wilson MF: Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia; Circ Shock. 1985, 17 (4), S.273-284

42. Browne MK, Leslie GB : Animal models of peritonitis; Surg Gynecol Obstet . 1976, 143 (5), S.738-740

43. Bruin KF, von der Mühlen MAM, van Deventer DJH : Endotoxemia and Sepsis: Important Roles for Lipop o lysaccharide Binding Protein and CD14 in Endotoxin Signal Transduction; Sepsis - current perspectives in pathophysiology and therapy. Berlin Heide l berg New York, Springer Verlag, 1994 S.53-60

44. Brunkhorst FM: Definition und Diagnose der Sepsis nach aktuellen Kriterien; Klinikarzt. 2004, 33 (6), S.167-172

45. Brunkhorst FM: Sepsis fordert viel mehr Todesopfer als gedacht; Gesundheitsforschung: Forschung für den Menschen. 2004, 17, S.2-4

46. Buttgereit F, Hiepe F, Burmester GR : Das therapeutische Potential der Lazaroide (21-Aminosteroide); Dtsch med Wschr. 1997, 122 (44), S.1363-1367

47. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW, Endres S, Lonnemann G, Corsetti J, Chernow B, et al.: Circulating interleukin-1 and tumor necrosis factor in septic shock and e x perimental endotoxin fever ; J Infect Dis. 1990, 161 (1), S.79-84

48. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple-organ-failure syndrome; Arch Surg . 1986, 121 (2), S.196-208

49. Chen H, Xu D, Qi S, Aboujaoude M, Senechal J, D a loze P: 21-Aminosteroid lipid peroxidation inhibitor U74389G protects the small bowel in the rat against warm and cold ischemia damage ; Transplant Proc. 1994, 26, S.1483-1484

50. Christman JW, Lancaster LH, Blackwell TS : Nuclear factor kappa B: a pivotal role in the systemic infla m matory response syndrome and new target for therapy ; Intensive Care Med . 1998, 24 (11), S.1131-1138

51. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity; Ann Surg. 1992, 215 (4), S.356-62

52. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE : Endotoxemia in human septic shock; Chest . 1991, 99 (1), S.169-175

53. Das UN: Critical advances in septicemia and septic shock ; Crit Care . 2000, 4 (5) , S.290-296

54. De-Carvalho H, Matos JA,Bouskela E, Svensjo E: Vascular permeability increase and plasma volume loss induced by endotoxin was attenuated by hypertonic saline with or without dextran; Shock. 1999, 12 (1), S.75-80

55. Deitch EA: Multiple organ failure. Pathophysiology and potential future therapy ; Ann Surg . 1992, 216 (2), S.117-134

56. Deitch EA, Bridges RM: Effect of stress and trauma on bacterial translocation from the gut; J Surg Res. 1987, 42 (5), S.536-542

57. Deitch EA, Ma L, Ma WJ, Grisham MB, Granger DN, Specian RD, Berg RD: Inhibition of endotoxin-induced bacterial translocation in mice; J Clin Invest . 1989, 84 (1), S.36-42

58. Deitch EA, Specian RD, Berg RD: Endotoxin-induced bacterial translocation and mucosal pe r meability: Role of xanthine oxidase, complement activation, and macrophage products ; Crit Care Med. 1991, 19 (6), S.785-791

59. Dellinger RP, Carlet JM, Masur H, Gerlach H, C a landra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM : Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock; Crit Care Med. 2004, 32 (3) , S.858-873

60. Dunzendorfer S, Lee HK, Soldau K, Tobias PS: TLR4 is the signaling but not the lipopolysaccharide uptake receptor; J Immunol . 2004, 173 (2), S.1166-1170

61. Engelberts I, Moller A, Leeuwenberg JF, van der Linden CJ, Buurman WA : Administration of tumor necr o sis factor alpha (TNF alpha) inhibitors after exposure to TNF alpha prevents development of the max i mal biological effect: An argument for clinical treatment with TNF alpha inhibitors; J Surg Res. 1992, 53 (5), S.510-514

62. Engelhardt L: Hrsg.: Medizinische Fakultät Charité der Humboldt-Universität zu Berlin: Einfluss von Methylprednisolon und Tirilazad Mesylat auf immunologische Parameter nach koronarer Bypassoperation - eine placebokontrollierte Studie. Dissertation. 2001

63. Eversole RR, Smith SL, Beuving LJ, Hall ED: Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate (U74006F) on hepatic endothelium in experimental hemorrhagic shock; Circ Shock. 1993, 40 (2), S.125-131

64. Fenton MJ, Golenbock DT: LPS-binding proteins and receptors ; J Leukoc Biol. 1998, 64 (1), S.25-32

65. Fiebig E, Ley K, Arfors KE : Rapid leukocyte accumulation by "spontaneous" rolling and adhesion in the exteriorized rabbit mesentery; Int J Microcirc Clin Exp . 1991, 10 (2), S.127-144

66. Fink MP: Leaky gut hypothesis: A historical perspective; Crit Care Med . 1990, 18 (5), S.579-580

67. Fink MP, Antonsson JB, Wang HL, Rothschild HR: Increased intestinal permeability in endotoxic pigs. M e senteric hypoperfusion as an etiologic factor; Arch Surg . 1991, 126 (2), S.211-218

68. Fink MP, Heard SO: Laboratory models of sepsis and septic shock; J Surg Res. 1990, 49 (2), S.186-196

69. Fong Y, Lowry SF: Tumor necrosis factor in the pathophysiology of infection and sepsis; Clin Immunol Immunopathol. 1990, 55 (2), S.157-170

70. Fong Y, Moldawer LL, Shires GT, Lowry SF : The biologic characteristics of cytokines and their implication in surgical injury; Surg Gynecol Obstet. 1990, 170 (4), S.363-378

71. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD: Soluble CD14 partic i pates in the responseof cells to lipopol y saccharide; J Exp Med. 1992, 176 (6), S.1665-1671

72. Friedman G, Berlot G, Kahn RJ, Vincent JL: Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis; Crit Care Med. 1995, 23 (7) , S.1184-1193

73. Fukumura D, Miura S, Kurose I, Higuchi H, Suzuki H, Ebinuma H, Han JY, Watanabe N, Wakabayashi G, Kitajima M, Ishii H: IL-1 is an important mediator for microcirculatory changes in endotoxin-induced intestinal mucosal damage; Dig Dis Sci . 1996, 41 (12), S.2482-2492

74. Ghosh S, Latimer RD, Gray BM, Harwood RJ, Oduro A: Endotoxin-induced organ injury; Crit Care Med . 1993, 21 (2 Suppl) , S.S19-S24

75. Giroir BP: Mediators of septic shock: New approaches for interrupting the endogenous inflammatory casc a de; Crit Care Med. 1993, 21 (5), S.780-789

76. Goode HF, Webster NR: Free radicals and antioxidants in sepsis; Crit Care Med . 1993, 21 (11), S.1770-1776

77. Granger DN, Hollwarth ME, Parks DA: Ischemia-reperfusion injury: Role of oxygen-derived free rad i cals; Acta Physiol Scand . 1986, Suppl 548, S.S47-S63

78. Granger DN, Kubes P: The microcirculation and inflammation: Modulation of leuk o cyte-endothelial cell adhesion ; J Leukoc Biol . 1994, 55 (5) , S.662-675

79. Granger DN, Richardson PD, Kvietys PR, Mortillaro NA: Intestinal blood flow ; Gastroenterology . 1980, 78 (4), S.837-863

80. Gray PW, Corcorran AE, Eddy-RL J, Byers MG, Shows TB: The genes for the lipopolysaccharide binding protein (LBP) and the bactericidal permeability increasing protein (BPI) are encoded in the same region of human chromosome 20; Genomics . 1993, 15 (1), S.188-190

81. Grisham MB, Everse J, Janssen HF: Endotoxemia and neutrophil activation in vivo; Am J Physiol . 1988, 254 (5 Pt 2), S.H1017-H1022

82. Grotz M, Regel G, Bastian L, Weimann A, Neuhoff K, Stalp M, Tscherne H : Der Darm als zentrales Organ in der Entwicklung des Multiorganversagens (MOV) nach schwerem Trauma- Pathophysiol o gie und therapeutische Ansätze; Zentralbl Chir . 1998., 123 (3), S.205-217

83. Grum CM, Fiddian Green RG, Pittenger GL, Grant BJ, Rothman ED, Dantzker DR: Adequacy of tissue ox y genation in intact dog intestine; J Appl Physiol . 1984, 56 (4), S.1065-1069

84. Haglund U, Bulkley GB, Granger DN: On the pathophysiology of intestinal ischemic injury. Clinical review ; Acta Chir Scand . 1987, 153 (5-6), S.321-324

85. Hall ED: Lipid antioxidants in acute central nervous system injury; Ann Emerg Med . 1993, 22 (6), S.1022-1027

86. Hall ED, McCall JM, Means ED: Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarac h noid hemorrhage; Adv Pharmacol . 1994, 28, S.221-268

87. Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CR: Recognition and plasma clearance of end o toxin by scavenger receptors ; Nature. 1991, 352 (6333), S.342-344

88. Harlan JM: Leukocyte-endothelial interactions ; Blood . 1985, 65 (3), S.513-525

89. Harris NR, Russell JM, Granger DN: Mediators of endotoxin-induced leukocyte adhesion in mese n teric postcapillary venules; Circ Shock . 1994, 43 (4), S.155-160

90. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Go y ert SM : The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. ; J Immunol . 1988, 141 (2), S.547-552

91. Haziot A, Katz I, Rong GW, Lin XY, Silver J, Goyert SM: Evidence that the receptor for soluble CD14:LPS complexes may not be the putative signal-transducing molecule associated with membrane-bound CD14; Scand J Immunol . 1997, 46 (3), S.242-245

92. Haziot A, Tsuberi BZ, Goyert SM: Neutrophil CD14: Biochemical properties and role in the secr e tion of tumor necrosis factor-alpha in response to lipopolysa c charide ; J Immunol . 1993, 150 (12), S.5556-5565

93. Hein OV, Ohring R, Schilling A, Oellerich M, Ar m strong VW, Kox WJ, Spies C : N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report; Crit Care . 2004, 8 (2), S.R66-R71

94. Hickey MJ, Issekutz AC, Reinhardt PH, Fedorak RN, Kubes P: Endogenous interleukin-10 regulates hem o dynamic parameters, leukocyte- endothelial cell interactions, and microvascular permeability during endotoxemia; Circ Res . 1998, 83 (11), S.1124-1131

95. Hinshaw LB, Emerson TE, Iampietro PF, Brake CM: A comparative study of the hemodynamic actions of histamie and endotoxin; Am J Physiol . 1962, 203 (4), S.600-606

96. Horton JW, Walker PB: Oxygen radicals, lipid peroxidation, and permeability changes after intestinal isch e mia and reperfusion ; J Appl Physiol . 1993, 74 (4), S.1515-1520

97. Hoyert DL, Anderson RN: Age-adjusted death rates: Trend data based on the year 2000 standard population ; Hrsg.: National Vital Statistics Reports: Band 49. 2001 S.1-6

98. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion; Cell . 1992, 69 (1), S.11-25

99. Janeway CA, Travers, P: Immunologie. Heidelberg, Berlin, Oxford , Spek t rum, 1997

100. Janssen GH, Tangelder, Reneman RS: Different effects of anesthetics on spontaneous leukocyte ro l ling in rat skin; Int J Microcirc Clin Exp . 1997, 17 (6), S.305-313

101. Janssen GH, Tangelder GJ, Reneman RS: Spontaneous leukocyte rolling in venules in untraumatized skin of conscious and anesthetized animals; Am J Physiol . 1994, 267 (3 Pt 2), S. H1199-H1204

102. Bunting SA, Wurm FM, Chamow SM, Ashkenazi A: Jin H, Yang R, Marsters SA, Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoa d hesin: comparison with anti-TNF monoclonal antibody ; J Infect Dis . 1994, 170 (5), S.1323-1326

103. Johnston TD, Hampton WW, Fry DE: Septic hemodynamics produced by infusion of endotoxin; Curr Surg . 1989, 46 (2), S.101-103

104. Jungi TW, Sager H, Adler H, Brcic M, Pfister H: Serum factors, cell membrane CD14, and beta2 integrins are not required for activation of bovine macrophages by lipopolysaccharide; Infect Immun . 1997, 65 (9), S.3577-3584

105. Kastner U, Glasl S, Lugauer S, Guggenbichler JP: Sepsis- Neue Erkenntnisse zur Pathophysiologie, Ther a pie und Prävention; Hrsg.: Antibiotika Mon i tor: S.1-20

106. Kayser FH, Bienz KA, Eckert J, Lindenmann J: Allgemeine Bakteriologie, Morphologie und Feinstruktur der Bakterien. In: Wiesmann E, ed. Medizinische Mikrobiologie (Immunologie, Bakteriologie, Mykologie, Virologie, Parasitologie). 7 Stuttgart - New York, Georg Thieme Verlag, 1989 S.73-81

107. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S: Indocyanine green elimination rate detects hepatocellular dy s function early in septic shock and correlates with survival; Crit Care Med. 2001, 29 (6), S.1159-1163

108. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M : Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide; J Exp Med . 1998, 188 (11), S.2091-2097

109. Kox W, Spies C: Check-up Anästhesiologie. Heide l berg, Springer Medizin Verlag, 2003

110. Kox WJ, Volk T, Kox SN, Volk HD: Immunomodulatory therapies in sepsis; Intensive Care Med . 2000, 26 (Suppl 1), S.S124-S128

111. Kretzschmar M: ole oxygen free radials in the pathophysiology of sepsis; Sepsis - current perspectives in pathophysiology and therapy. Berlin, Heide l berg, New York, Springer Verlag, 1994 S.122-135

112. Kreymann G. WM: Geschichte und Definition der Sepsis - Brauchen wir eine neue Terminologie? Anasth e siol ; Intensivmed Notfallmed Schmerzther . 1996, 31 (1), S.9-14

113. Kubes P, Grisham MB, Barrowman JA, Gaginella T, Granger DN: Leukocyte-induced vascular protein leakage in cat mesentery. ; Am J Physiol . 1991, 261 (6 Pt 2), S.H1872-H1879

114. Kuebler WM, Borges J, Sckell A, Kuhnle GE, Bergh K, Messmer K, Goetz AE: Role of L-selectin in leuk o cyte sequestration in lung capillaries in a rabbit model of endotoxemia ; Am J Respir Crit Care Med . 2000, 161 (1), S.36-43

115. Kuhns DB, Alvord WG, Gallin JI : Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in h u mans; J Infect Dis . 1995, 171 (1), S.145-152

116. Kurose I, Suematsu M, Miura S, Fukumura D, Sekiz u ka E, Nagata H, Oshio C, Tsuchiya M : Oxyradical generation from leukocytes during endotoxin-induced microcirculatory disturbance in rat mesentery-attenuating effect of cetraxate; Toxicol Appl Pharmacol . 1993, 120 (1) , S.37-44

117. Küttler T: Pharmakologie und Toxikologie. 16 Neckarsulm Stuttgart, Jungjohann Verlagsgesel l schaft, 1994 S.113,254

118. Lehmann C, Georgiew A, Weber M, Birnbaum J, Kox WJ: Reduction in intestinal leukocyte adherence in rat experimental endotoxemia by treatment with the 21-aminosteroid U-74389G; Intensive Care Med . 2001, 27 (1), S.258-63

119. Lenhartz H: Die septischen Erkrankungen . Wien, Hölder, 1903

120. Lentsch AB, Ward PA: Activation and regulation of NFkappaB during acute inflamm a tion; Clin Chem Lab Med . 1999, 37 (3), S.205-208

121. Ley K: Histamine can induce leukocyte rolling in rat mesenteric ven u les; Am J Physiol . 1994, 267 (3 Pt 2), S.H1017-H1023

122. Ley K: Leukocyte adhesion to vascular endothelium; J Reconstr Microsurg . 1992, 8 (6), S.495-503

123. Ley K, Tedder TF: Leukocyte interactions with vascular endothelium. New i n sights into selectin-mediated attachment and rolling; J Immunol . 1995, 155 (2), S.525-528

124. Linde-Zwirble WT, Angus DC: Severe sepsis epidemiology: sampling, selection, and society; Crit Care. 2004, 8 (4), S.222-226

125. Loppnow H: Cytokines: Classification, receptors, mechanisms of action; Internist . 2001, 42 (1) , S.13-4, 17-27

126. Luther B, Burger K, Paul D, Lehmann C, Buchali K: Zur Pathophysiologie der intestinalen Blutzirkulation. Tiere x perimentelle Ergebnisse; Angio . 1990, 12 (5), S.173-184

127. Maejima K, Deitch E, Berg R. : Promotion by burn stress of the translocation of bacteria from the gastroi n testinal tracts of mice; Arch Surg . 1984, 119 (2), S.166-172

128. Maejima K, Deitch EA, Berg RD: Bacterial translocation from the gastrointestinal tracts of rats receiving thermal injury; Infect Immun . 1984, 43 (1), S.6-10

129. Marshall JC, Christou NV, Meakins JL: The gastrointestinal tract. The "undrained abscess" of multiple organ failure; Ann Surg . 1993, 218 (2), S.111-119

130. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000; N Engl J Med . 2003, 348 (16), S.1546-1554

131. Martin TR, Mathison JC, Tobias PS, Leturcq DJ, Moriarty AM, Maunder RJ, Ulevitch RJ: Lipopolysacch a ride binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysacchar i de. Implications for cytokine production in normal and injured lungs ; J Clin Invest . 1992, 90 (6), S.2209-2219

132. Massignon D, Lepape A, Bienvenu J, Barbier Y, Bo i leau C, Coeur P: Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state; Haemostasis . 1994, 24 (1), S.36-48

133. Mayrovitz HN: Leukocyte rolling: A prominent feature of venules in intact skin of anesthetized hairless mice; Am J Physiol . 1992, 262 (1 Pt 2), S.H157-H161

134. McKechnie K, Furman BL, Parratt JR: Modification by oxygen free radical scavengers of the metab o lic and cardiovascular effects of endotoxin infusion in consc i ous rats; Circ Shock . 1986, 19 (4), S.429-439

135. Minamiya Y, Abo S, Kitamura M, Izumi K, Kimura Y, Tozawa K, Saito S: Endotoxin-induced hydrogen peroxide production in intact pulmonary circulation of rat; Am J Respir Crit Care Med. 1995, 152 (1), S.348-354

136. Miura S, Tsuzuki Y, Kurose I, Suematsu M, Shigema t su T, Kimura H, Higuchi H, Serizawa H, Yagita H, Okumura K, Granger DN, Ishii H: Endotoxin stimulates lymphocyte-endothelial interactions in rat i n testinal Peyer's patches and villus mucosa; Am J Physiol . 1996, 271 (2 Pt 1), S.G282-G292

137. Moazzam F, Delano FA, Zweifach BW, Schmid-Schoenbein GW: The leukocyte response to fluid stress; Proc Natl Acad Sci USA . 1997, 94 (10), S.5338-5343

138. Moerer O, Schmid A, Hofmann M, Herklotz A, Rei n hart K, Werdan K, Schneider H, Burchardi H: Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient r e cord analysis of resource use; Intensive Care Med . 2002, 28 (10), S.1440-1446

139. Morgan RA, Manning PB, Coran AG, Drongowski RA, Till GO, Ward PD, Oldham KT: Oxygen free rad i cal activity during live E. coli septic shock in the dog ; Circ Shock . 1988, 25 (4), S.319-323

140. Moskopp DWH: Zerebroprotektive Maßnahmen bei Energiekrisen des Gehirns. Zülpich, Bie r mann Verlag, 1994 S.142-148

141. Mullen PG, Fisher BJ, Walsh CJ, Susskind BM, Le e per-Woodford SK, Jesmok GJ, Fowler AA, Sugerman HJ: Monoclonal antibody to tumor necrosis factor-alpha attenuates plasma interleukin-6 levels in porc i ne gram-negative sepsis; J Surg Res. 1994, 57 (5), S.625-31

142. Nakayama M, Hasegawa N, Oka Y, Lutzke B, McCall JM, Raffin TA: Effects of the lazaroid, tirilazad m e sylate, on sepsis-induced acute lung injury in minipigs; Crit Care Med . 1998, 26 (3), S.538-547

143. Navaratnam RL, Morris SE, Traber DL, Flynn J, Woodson L, Linares H, Herndon DN: Endotoxin (LPS) increases mesenteric vascular resistance (MVR) and bacterial translocation (BT); J Trauma . 1990, 30 (9), S.1104-1113

144. Netea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW, Kullberg BJ: The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis; J Infect Dis . 2002, 185 (10), S.1483-1489

145. Neugebauer E, Rixen D, Raum M, Schafer U: Thirty years of anti-mediator treatment in sepsis and septic shock- what have we learned? ; Langenbecks Arch Surg. 1998, 383 (1), S.26-34

146. Neugebauer EAH: Handbook of Mediators in Septic Shock. Florida, USA, CRC Press, Inc., 1993 S.565

147. Neviere RR, Pitt HM, Piper RD, Sibbald WJ, Potter RF: Microvascular perfusion deficits are not a prer e quisite for m u cosal injury in septic rats; Am J Physiol. 1999, 276 (4 Pt 1), S.G933-G940

148. Nolte D, Hecht R, Schmid P, Botzlar A, Menger MD, Neumueller C, Sinowatz F, Vestweber D, Messmer K: Role of Mac-1 and ICAM-1 in ischemia-reperfusion injury in a microcirculation model of BALB/C m i ce; Am J Physiol . 1994, 267 (4 Pt 2), S.H1320-H1328

149. Oka Y, Murata A, Nishijima J, Yasuda T, Hiraoka N, Ohmachi Y, Kitagawa K, Toda H, Tanaka N, et al. : Circulating interleukin 6 as a useful marker for predicting pos t operative complications; Cytokine . 1992, 4 (4), S.298-304

150. Opal SM, Cohen J: Clinical gram-positive sepsis: Does it fundamentally differ from gram-negative bacterial sepsis? ; Crit Care Med. 1999, 27 (8), S.1608-1616

151. Ortolani O, Conti A, De-Gaudio AR, Moraldi E, Ca n tini Q, Novelli G : The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock; Am J Respir Crit Care Med . 2000, 161 (6), S.1907-1911

152. Pena LA, Fuks Z, Kolesnick R : Stress-induced apoptosis and the sphingomyelin pathway; Biochem Pharmacol . 1997, 53 (5), S.615-621

153. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock. Relation to mu l tiple-system organ failure and mortality; Chest . 1993, 103 (2), S.565-575

154. Powell RJ, Machiedo GW, Rush-BF J, Dikdan GS: Effect of oxygen-free radical scavengers on survival in sepsis; Am Surg . 1991, 57 (2), S.86-88

155. Quezado ZMN, Natanson C, Hoffmann WD: Endotoxin in Septic Shock. In: Reinhart K, Eyrich K, eds. Sepsis - current perspectives in pathophysiology and therapy. Berlin Heidelberg New York , Springer Verlag, 1994 S.314-336

156. Radetsky M: The discovery of penicillin; Pediatr Infect Dis J . 1996, 15 (9), S.811-818

157. Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C: N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, random i zed, double-blind study; Crit Care Med . 2000, 28 (12), S.3799-3807

158. Redondo P, Subira ML: N-acetylcysteine inhibits production of tumor necrosis factor alpha and interleukin-1 beta; Arch Intern Med . 1996, 156 (11) , S.1238, 1241

159. Reinhart K : Leitlinie Diagnose und Therapie der Sepsis- Methodenreport; Hrsg.: Deutsche Sepsis-Gesel l schaft e.V.: 2005

160. Reinhart KB, Bloos F : Fortschritte in der Therapie der Sepsis; Deutsches Ärzteblatt. 2003, 100 (31-32), S.2080-2086

161. Revhaug A, Michie HR, Manson JM, Watters JM, Dinarello CA, Wolff SM, Wilmore DW: Inhibition of cyclo-oxygenase attenuates the metabolic respo n se to endotoxin in humans ; Arch Surg . 1988, 123 (2), S.162-170

162. Riede U-N, Schaefer H-E: Allgemeine und spezielle Pathologie. 3 Stuttgart, New York, Georg Thieme Ve r lag, 1993

163. Rohr U: Hrsg.: Medizinischen Fakultät Charité der Humboldt-Universität zu Berlin: sCD14, TNF, Interleukin-6, sICAM-1 und sE-Selektin im septischen Geschehen. Dissertation . 1998

164. Roth E, Manhart N, Punz A: Role of antioxidants in Sepsis; Intensivmedizin . 1998, 35 (2) , S.95-105

165. Rychlik R: Sozioökonomische Relevanz der Sepsis in Deutschland; Gesundh Ökon Qual Manag. 2001, 5, S.67-72

166. Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, Macarthur H, Misko TP: Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intest i nal damage; Br J Pharmacol . 1999, 127 (3), S.685-692

167. Scalia R, Armstead VE, Minchenko AG, Lefer AM: Essential role of P-selectin in the initiation of the i n flammatory response induced by hemorrhage and reinfusion; J Exp Med . 1999, 189 (6), S.931-93

168. Schiller HJ, Reilly PM, Bulkley GB: Tissue perfusion in critical illnesses. Antioxidant therapy; Crit Care Med . 1993, 21, S.92-102

169. Schmidt H: Hrsg.: Ruprecht-Karls-Universität Heidelberg: Tierexperimentelle Untersuchungen zur intestinalen Mikrozirkulation und zum intestinalen Purinstoffwechsel bei Endotoxinämie. Habilitation . 1997

170. Schmidt H, Ebeling D, Bauer H, Bach A, Böhrer H, Gebhard MM, Martin E: Ketamine attenuates endot o xin-induced leukocyte adherence in rat mesenteric venules; Crit Care Med . 1995, 23 (12), S.2008-2014

171. Schmidt H, Schmidt W, Müller T, Böhrer H, Bach A, Gebhard MM, Martin E : Effect of the 21-aminosteroid tirilazad mesylate on leukocyte adhesion and macromolecular leakage during endotox e mia; Surgery . 1997, 121 (3), S.328-334

172. Schmidt H, Schmidt W, Müller T, Böhrer H, Gebhard MM, Martin E : N-acetylcysteine attenuates endot o xin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo; Crit Care Med. 1997, 25 (5), S.858-863

173. Schmidt H, Secchi A, Wellmann R, Bach A, Böhrer H, Gebhard MM, Martin E: Effect of endotoxemia on intestinal villus microcirculation in rats; J Surg Res . 1996, 61 (2), S.521-526

174. Schmidt W, Schmidt H, Bauer H, Gebhard MM, Ma r tin E: Influence of lidocaine on endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo; Anesthesiology . 1997, 87 (3) , S.617-624

175. Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H: Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances; Intensive Care Med . 1998, 24 (9), S.967-972

176. Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H: Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances; Intensive Care Med. 1998, 24 (9): , S.967-972,

177. Schneider J, Friderichs E, Heintze K, Flohe L: Effects of recombinant human superoxide dismutase on increased lung vascular permeability and respiratory disorder in endotoxemic rats; Circ Shock. 1990, 30, S.97-106

178. Schottmüller H: Wesen und Behandlung der Sepsis; Verhandl dt Kongress Inn Med . 1914, 31, S.257-280

179. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ: Stru c ture and function of lipopolysaccharide binding protein ; Science . 1990, 249 (4975), S.1429-1431

180. Schuster HP, Werdan K: Intensivtherapie bei Sepsis und Multiorganversagen . 3 Berlin, Heide l berg, New York, Barcelona, Hon g kong, London, Mailand, Paris, Singapur, Tokio, Springer Verlag, 2000

181. Seiffge D, Bissinger T, Kremer E, Laux V, Schleye r bach R: Inhibitory effects of pentoxifylline on LPS-induced leukocyte adhesion and macromolecular extravasation in the microcirculation; Inflamm Res . 1995, 44 (7), S.281-286

182. Semrad SD, Rose ML, Adams JL: Effect of tirilazad mesylate (U74006F) on eicosanoid and t u mor necrosis factor generation in healthy and endotoxemic neonatal calves ; Circ Shock . 1993, 40 (4),

183. Shong M, Ro HK, Kim YK, Yoo CJ, Lee JH, Song CU, Cho BY: The cytokines , interleukin-1 beta, inte r leukin-6, and interf e ron-gamma upregulate the expression of intercellular adhesion molecule-1 (ICAM-1) in rat thyreoid cell line, FRTL-5; Korean J Intern Med . 1994, 9 (2), S.88-92

184. Slade E, Tamber PS, Vincent JL : The Surviving Sepsis Campaign: Raising awareness to reduce mortality; Crit Care . 2003, 7 (1), S.1-2

185. Spapen H, Zhang H, Demanet C, Vleminckx W, Vincent JL, Huyghens L: Does N-acetyl-L-cysteine i n fluence cytokine response during early human septic shock?; Chest . 1998, 113 (6), S.1616-24

186. Spies CD, Reinhart K, Witt I, Meier HA, Hannemann L, Bredle DL, Schaffartzik W: Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospect i ve, randomized, double-blind study; Crit Care Med . 1994, 22 (11), S.1738-1746

187. Springer TA: Adhesion receptors of the immune system; Nature . 1990, 346 (6283), S.425-434

188. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm ; Cell . 1994, 76 (2), S.301-314

189. Steinmetz HT, Herbertz A, Bertram M, Diehl V : Increase in interleukin-6 serum level preceding fever in gran u locytopenia and correlation with death from sepsis; J Infect Dis . 1995, 171 (1), S.225-228

190. Thiel M, Zourelidis C, Peter K: The role of polymorphonuclear neutrophilic leukocytes in the pathogenesis of acute respiratory distress syndrome (ARDS); Anaesthesist . 1996, 45 (2), S.113-130

191. Tonnesen MG: Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium; J Invest Dermatol . 1989, 93 (2 Suppl), S.S53-S58

192. Van Lambalgen AA, Rasker MT, van den Bos GC, Thijs LG: Effects of endotoxemia on systemic plasma loss and hematocrit in rats; Microvasc Res . 1988, 36, S.291-304

193. van Lambalgen AA, van den Bos GC, Thijs LG: Changes in regional plasma extravasation in rats following endotoxin infusion; Microvasc Res . 1987, 34 (1), S.116-132

194. Volk T, Hensel M, Schuster H, Kox WJ : Secretion of MCP-1 and IL-6 by cytokine stimulated product i on of reactive oxygen species in endothelial cells ; Mol Cell Biochem . 2000, 206 (1-2), S.105-112

195. von-Andrian UH, Berger EM, Ramezani L, Chambers JD, Ochs HD, Harlan JM, Paulson JC, Etzioni A, A r fors KE: In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes; J Clin Invest . 1993, 91 (6), S.2893-2897

196. Warner A, Bencosme A, Healy D, Verme C : Prognostic role of antioxidant enzymes in sepsis: preliminary assessment; Clin Chem . 1995, 41 (6 Pt 1), S.867-871

197. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock - A review of laboratory models and a proposal; J Surg Res . 1980, 29, S.189-200

198. Xu D, Qi L, Guillory D, Cruz N, Berg R, Deitch EA : Mechanisms of endotoxin-induced intestinal injury in a hype r dynamic model of sepsis; J Trauma . 1993, 34 (5), S.676-682

199. Yi ES, Ulich TR: Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microva s cular leakage in postcapillary venules; Am J Pathol . 1992, 140 (3), S.659-663

200. Yuan Y, Fleming BP: A method for isolation and fluorescent labeling of rat neutrophils for intravital micr o vascular studies; Microvasc Res. 1990, 40, S.218-229

201. Zander R: Arterial-intramuscular C02-partial pressure difference (aiDC02); Anasthesiol Intensivmed Notfallmed Schmerzther . 1998, 33 Suppl 2, S.S52-S53

202. Zhang H, Spapen H, Manikis P, Rogiers P, Metz G, Buurman WA, Vincent JL: Tirilazad mesylate (U-74006F) inhibits effects of endotoxin in dogs; Am J Physiol . 1995, 268 (5 Pt 2), S.H1847-H1855

203. Zhang H, Spapen H, Nguyen DN, Benlabed M, Buu r man WA, Vincent JL: Protective effects of N-acetyl-L-cysteine in endotoxemia; Am J Physiol . 1994, 266 (5 Pt 2), S.H1746-H1754

204. Zhang H, Spapen H, Nguyen DN, Rogiers P, Bakker J, Vincent JL: Effects of N-acetyl-L-cysteine on regi o nal blood flow during endotoxic shock; Eur Surg Res . 1995, 27 (5), S.292-300

205. Ziegler E: Lehrbuch der Allgemeinen Pathologie und der pathologischen Anatomie. Jena, Fischer Verlag, 1905

206. Ziegler-Heitbrock HW, Ulevitch RJ : CD14: cell surface receptor and differentiation marker; Immunol Today . 1993, 14 (3), S.121-125

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: